Literature DB >> 8186960

Leg weakness due to stroke. Site of lesions, weakness patterns and causes.

R Schneider1, J C Gautier.   

Abstract

Among 1575 patients with an acute stroke, 63 (4%) were found to have a leg-predominant weakness. The cerebral lesions were situated in (i) the anterior cerebral artery (ACA) territory in 12 cases, including one patient with a thrombosis of the sagittal sinus; (ii) the middle cerebral artery (MCA) territory in nine cases; (iii) both territories (not watershed) in two cases; (iv) the internal capsule in 18 cases, of which six cases had lesions in the ponto-peduncular or pontine; (v) other brainstem regions in 10 cases; (iv) the thalamus in two cases. Four were not precisely classified. In short, 41 were hemispheric and 18 were in the brainstem or thalamus. Lesions restricted to the rear portion of the medial part of the precentral gyrus caused a contralateral predominantly distal leg weakness. The weakness was severe with little improvement. Lesions involving the medial part of the premotor cortex, the supplementary motor area (SMA) and the rear portion of the medial part of the precentral gyrus caused a contralateral, severe leg-predominant hemiplegia, distally predominant and a less severe proximal weakness of the arm. Recovery was much better for the arm than for the leg. Lesions affecting the medial part of the premotor cortex, the SMA and sparing the precentral gyrus caused a contralateral hemiparesis predominating on the leg but predominating proximally on both leg and arm. Recovery was good for leg and arm. There were 22 infarcts due to ACA or MCA occlusion, one due to superior sagittal sinus occlusion, 18 lacunes and five haemorrhages.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8186960     DOI: 10.1093/brain/117.2.347

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  8 in total

1.  Topographic organization of motor fibre tracts in the human brain: findings in multiple locations using magnetic resonance diffusion tensor tractography.

Authors:  Dong-Hoon Lee; Do-Wan Lee; Bong-Soo Han
Journal:  Eur Radiol       Date:  2015-09-24       Impact factor: 5.315

2.  Microstructural integrity of corticospinal and medial lemniscus tracts: insights from diffusion tensor tractography of right-hand amputees.

Authors:  Huiling Peng; Carmen M Cirstea; Christina L Kaufman; Scott H Frey
Journal:  J Neurophysiol       Date:  2019-05-22       Impact factor: 2.714

3.  Clinical and MRI patterns of pericallosal artery infarctions: the significance of supplementary motor area lesions.

Authors:  Angelika Alonso; Achim Gass; Christina Rossmanith; Rolf Kern; Martin Griebe; Johannes Binder; Michael G Hennerici; Kristina Szabo
Journal:  J Neurol       Date:  2011-11-05       Impact factor: 4.849

4.  Isolated monoparesis following stroke.

Authors:  M Paciaroni; V Caso; P Milia; M Venti; G Silvestrelli; F Palmerini; K Nardi; S Micheli; G Agnelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

5.  Effects of edaravone on muscle atrophy and locomotor function in patients with ischemic stroke: a randomized controlled pilot study.

Authors:  Hiroaki Naritomi; Hiroshi Moriwaki; Norifumi Metoki; Hiroyuki Nishimura; Yasuto Higashi; Yasumasa Yamamoto; Hiroyuki Yuasa; Hiroshi Oe; Kortaro Tanaka; Kozue Saito; Yasuo Terayama; Tadafumi Oda; Norio Tanahashi; Hisao Kondo
Journal:  Drugs R D       Date:  2010

Review 6.  Somatotopic arrangement and location of the corticospinal tract in the brainstem of the human brain.

Authors:  Sung Ho Jang
Journal:  Yonsei Med J       Date:  2011-07       Impact factor: 2.759

7.  Paroxysmal freezing of gait in a patient with mesial frontal transient ischemic attacks.

Authors:  Hee Won Hwang; Seung Ha Lee; Chul Hyoung Lyoo; Myung Sik Lee
Journal:  BMC Neurol       Date:  2017-06-28       Impact factor: 2.474

8.  Foot force direction control during a pedaling task in individuals post-stroke.

Authors:  Jing Nong Liang; David A Brown
Journal:  J Neuroeng Rehabil       Date:  2014-04-16       Impact factor: 4.262

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.